Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000797682 | SCV000937255 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 633 of the DCLRE1C protein (p.Glu633Gly). This variant is present in population databases (rs533771936, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 643878). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV001563938 | SCV001786999 | uncertain significance | Histiocytic medullary reticulosis | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000797682 | SCV001787000 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275796 | SCV001461356 | uncertain significance | Athabaskan severe combined immunodeficiency | 2020-03-10 | no assertion criteria provided | clinical testing |